세계의 희귀 혈액학 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측

■ 영문 제목 : Global Rare Hematology Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Globalinforesearch가 발행한 조사보고서이며, 코드는 GIR9075002 입니다.■ 상품코드 : GIR9075002
■ 조사/발행회사 : Globalinforesearch
■ 발행일 : 2019년 5월 13일
■ 페이지수 : 115
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : Medical Devices & Consumables
■ 판매가격 / 옵션 (부가세별도)
Single User (1명 열람용)USD3,480 ⇒환산₩4,036,800견적의뢰/주문/질문
Multi User (5명 열람용)USD5,220 ⇒환산₩6,055,200견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD6,960 ⇒환산₩8,073,600견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
본 조사보고서는 희귀 혈액학의 세계시장에 대해서 조사분석한 자료로서, 희귀 혈액학의 세계시장 개요, 시장동향, 종류/용도별 시장규모, 지역별 분석 (북미, 유럽, 아시아, 남미, 중동/아프리카), 관련기업 정보등이 포함되어 있습니다.
・세계의 희귀 혈액학시장동향
・관련기업 개요 (사업개요, 제품종류, 판매동향, 시장점유율)
・주요 지역별 희귀 혈액학 시장분석/시장규모
  - 북미시장 (미국, 캐나다, 멕시코)
  - 유럽시장 (독일, 영국, 프랑스, 러시아, 이탈리아)
  - 아시아시장 (중국, 일본, 한국, 인도, 동남아시아)
  - 남미시장 (브라질, 아르헨티나, 콜롬비아)
  - 중동/아프리카시장 (사우디아라비아, 터키, 이집트, 나이지리아, 남아프리카)
・희귀 혈액학의 종류별 시장분석/시장규모
・희귀 혈액학의 용도별 시장분석/시장규모
・희귀 혈액학의 세계시장 예측 (지역별 예측, 종류별/용도별 시장예측)
・희귀 혈액학의 판매채널, 유통업체 분석
...
■ 보고서 개요

Scope of the Report:
The global Rare Hematology market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rare Hematology.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rare Hematology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rare Hematology market by product type and applications/end industries.

Market Segment by Companies, this report covers
Shire plc
Novo Nordisk A/S
Pfizer Inc.
Bayer Healthcare AG
CSL Behring LLC
Biogen Inc.
Alexion Pharmaceuticals, Inc.
Celgene Corporation
Amgen Inc.
PRA Health Sciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Recombinant Factors
Plasma Derived Factors

Market Segment by Applications, can be divided into
Pediatric
Adult

■ 보고서 목차

Table of Contents

1 Rare Hematology Market Overview
1.1 Product Overview and Scope of Rare Hematology
1.2 Classification of Rare Hematology by Types
1.2.1 Global Rare Hematology Revenue Comparison by Types (2019-2024)
1.2.2 Global Rare Hematology Revenue Market Share by Types in 2018
1.2.3 Recombinant Factors
1.2.4 Plasma Derived Factors
1.3 Global Rare Hematology Market by Application
1.3.1 Global Rare Hematology Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Pediatric
1.3.3 Adult
1.4 Global Rare Hematology Market by Regions
1.4.1 Global Rare Hematology Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Rare Hematology Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rare Hematology Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rare Hematology Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Rare Hematology Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rare Hematology Status and Prospect (2014-2024)
1.5 Global Market Size of Rare Hematology (2014-2024)
2 Manufacturers Profiles
2.1 Shire plc
2.1.1 Business Overview
2.1.2 Rare Hematology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Shire plc Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novo Nordisk A/S
2.2.1 Business Overview
2.2.2 Rare Hematology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novo Nordisk A/S Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer Inc.
2.3.1 Business Overview
2.3.2 Rare Hematology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bayer Healthcare AG
2.4.1 Business Overview
2.4.2 Rare Hematology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Healthcare AG Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.5 CSL Behring LLC
2.5.1 Business Overview
2.5.2 Rare Hematology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CSL Behring LLC Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.6 Biogen Inc.
2.6.1 Business Overview
2.6.2 Rare Hematology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biogen Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.7 Alexion Pharmaceuticals, Inc.
2.7.1 Business Overview
2.7.2 Rare Hematology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Alexion Pharmaceuticals, Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.8 Celgene Corporation
2.8.1 Business Overview
2.8.2 Rare Hematology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corporation Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.9 Amgen Inc.
2.9.1 Business Overview
2.9.2 Rare Hematology Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Amgen Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
2.10 PRA Health Sciences
2.10.1 Business Overview
2.10.2 Rare Hematology Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 PRA Health Sciences Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rare Hematology Market Competition, by Players
3.1 Global Rare Hematology Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Rare Hematology Players Market Share
3.2.2 Top 10 Rare Hematology Players Market Share
3.3 Market Competition Trend
4 Global Rare Hematology Market Size by Regions
4.1 Global Rare Hematology Revenue and Market Share by Regions
4.2 North America Rare Hematology Revenue and Growth Rate (2014-2019)
4.3 Europe Rare Hematology Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Rare Hematology Revenue and Growth Rate (2014-2019)
4.5 South America Rare Hematology Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Rare Hematology Revenue and Growth Rate (2014-2019)
5 North America Rare Hematology Revenue by Countries
5.1 North America Rare Hematology Revenue by Countries (2014-2019)
5.2 USA Rare Hematology Revenue and Growth Rate (2014-2019)
5.3 Canada Rare Hematology Revenue and Growth Rate (2014-2019)
5.4 Mexico Rare Hematology Revenue and Growth Rate (2014-2019)
6 Europe Rare Hematology Revenue by Countries
6.1 Europe Rare Hematology Revenue by Countries (2014-2019)
6.2 Germany Rare Hematology Revenue and Growth Rate (2014-2019)
6.3 UK Rare Hematology Revenue and Growth Rate (2014-2019)
6.4 France Rare Hematology Revenue and Growth Rate (2014-2019)
6.5 Russia Rare Hematology Revenue and Growth Rate (2014-2019)
6.6 Italy Rare Hematology Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Rare Hematology Revenue by Countries
7.1 Asia-Pacific Rare Hematology Revenue by Countries (2014-2019)
7.2 China Rare Hematology Revenue and Growth Rate (2014-2019)
7.3 Japan Rare Hematology Revenue and Growth Rate (2014-2019)
7.4 Korea Rare Hematology Revenue and Growth Rate (2014-2019)
7.5 India Rare Hematology Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Rare Hematology Revenue and Growth Rate (2014-2019)
8 South America Rare Hematology Revenue by Countries
8.1 South America Rare Hematology Revenue by Countries (2014-2019)
8.2 Brazil Rare Hematology Revenue and Growth Rate (2014-2019)
8.3 Argentina Rare Hematology Revenue and Growth Rate (2014-2019)
8.4 Colombia Rare Hematology Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Rare Hematology by Countries
9.1 Middle East and Africa Rare Hematology Revenue by Countries (2014-2019)
9.2 Saudi Arabia Rare Hematology Revenue and Growth Rate (2014-2019)
9.3 UAE Rare Hematology Revenue and Growth Rate (2014-2019)
9.4 Egypt Rare Hematology Revenue and Growth Rate (2014-2019)
9.5 Nigeria Rare Hematology Revenue and Growth Rate (2014-2019)
9.6 South Africa Rare Hematology Revenue and Growth Rate (2014-2019)
10 Global Rare Hematology Market Segment by Type
10.1 Global Rare Hematology Revenue and Market Share by Type (2014-2019)
10.2 Global Rare Hematology Market Forecast by Type (2019-2024)
10.3 Recombinant Factors Revenue Growth Rate (2014-2024)
10.4 Plasma Derived Factors Revenue Growth Rate (2014-2024)
11 Global Rare Hematology Market Segment by Application
11.1 Global Rare Hematology Revenue Market Share by Application (2014-2019)
11.2 Rare Hematology Market Forecast by Application (2019-2024)
11.3 Pediatric Revenue Growth (2014-2019)
11.4 Adult Revenue Growth (2014-2019)
12 Global Rare Hematology Market Size Forecast (2019-2024)
12.1 Global Rare Hematology Market Size Forecast (2019-2024)
12.2 Global Rare Hematology Market Forecast by Regions (2019-2024)
12.3 North America Rare Hematology Revenue Market Forecast (2019-2024)
12.4 Europe Rare Hematology Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Rare Hematology Revenue Market Forecast (2019-2024)
12.6 South America Rare Hematology Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Rare Hematology Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Rare Hematology Picture
Table Product Specifications of Rare Hematology
Table Global Rare Hematology and Revenue (Million USD) Market Split by Product Type
Figure Global Rare Hematology Revenue Market Share by Types in 2018
Figure Recombinant Factors Picture
Figure Plasma Derived Factors Picture
Table Global Rare Hematology Revenue (Million USD) by Application (2014-2024)
Figure Rare Hematology Revenue Market Share by Applications in 2018
Figure Pediatric Picture
Figure Adult Picture
Table Global Market Rare Hematology Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Rare Hematology Revenue (Million USD) and Growth Rate (2014-2024)
Table Shire plc Basic Information, Manufacturing Base and Competitors
Table Shire plc Rare Hematology Type and Applications
Table Shire plc Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk A/S Rare Hematology Type and Applications
Table Novo Nordisk A/S Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Rare Hematology Type and Applications
Table Pfizer Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Healthcare AG Basic Information, Manufacturing Base and Competitors
Table Bayer Healthcare AG Rare Hematology Type and Applications
Table Bayer Healthcare AG Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table CSL Behring LLC Basic Information, Manufacturing Base and Competitors
Table CSL Behring LLC Rare Hematology Type and Applications
Table CSL Behring LLC Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Inc. Basic Information, Manufacturing Base and Competitors
Table Biogen Inc. Rare Hematology Type and Applications
Table Biogen Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Alexion Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Alexion Pharmaceuticals, Inc. Rare Hematology Type and Applications
Table Alexion Pharmaceuticals, Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table Celgene Corporation Rare Hematology Type and Applications
Table Celgene Corporation Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table Amgen Inc. Rare Hematology Type and Applications
Table Amgen Inc. Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table PRA Health Sciences Basic Information, Manufacturing Base and Competitors
Table PRA Health Sciences Rare Hematology Type and Applications
Table PRA Health Sciences Rare Hematology Revenue, Gross Margin and Market Share (2017-2018)
Table Global Rare Hematology Revenue (Million USD) by Players (2014-2019)
Table Global Rare Hematology Revenue Share by Players (2014-2019)
Figure Global Rare Hematology Revenue Share by Players in 2017
Figure Global Rare Hematology Revenue Share by Players in 2018
Figure Global Top 5 Players Rare Hematology Revenue Market Share in 2018
Figure Global Top 10 Players Rare Hematology Revenue Market Share in 2018
Figure Global Rare Hematology Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Rare Hematology Revenue (Million USD) by Regions (2014-2019)
Table Global Rare Hematology Revenue Market Share by Regions (2014-2019)
Figure Global Rare Hematology Revenue Market Share by Regions (2014-2019)
Figure Global Rare Hematology Revenue Market Share by Regions in 2018
Figure North America Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Europe Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Rare Hematology Revenue and Growth Rate (2014-2019)
Figure South America Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Rare Hematology Revenue and Growth Rate (2014-2019)
Table North America Rare Hematology Revenue by Countries (2014-2019)
Table North America Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure North America Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure North America Rare Hematology Revenue Market Share by Countries in 2018
Figure USA Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Canada Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Mexico Rare Hematology Revenue and Growth Rate (2014-2019)
Table Europe Rare Hematology Revenue (Million USD) by Countries (2014-2019)
Figure Europe Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure Europe Rare Hematology Revenue Market Share by Countries in 2018
Figure Germany Rare Hematology Revenue and Growth Rate (2014-2019)
Figure UK Rare Hematology Revenue and Growth Rate (2014-2019)
Figure France Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Russia Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Italy Rare Hematology Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Rare Hematology Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Rare Hematology Revenue Market Share by Countries in 2018
Figure China Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Japan Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Korea Rare Hematology Revenue and Growth Rate (2014-2019)
Figure India Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Rare Hematology Revenue and Growth Rate (2014-2019)
Table South America Rare Hematology Revenue by Countries (2014-2019)
Table South America Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure South America Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure South America Rare Hematology Revenue Market Share by Countries in 2018
Figure Brazil Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Argentina Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Colombia Rare Hematology Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Rare Hematology Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rare Hematology Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rare Hematology Revenue Market Share by Countries in 2018
Figure Saudi Arabia Rare Hematology Revenue and Growth Rate (2014-2019)
Figure UAE Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Egypt Rare Hematology Revenue and Growth Rate (2014-2019)
Figure Nigeria Rare Hematology Revenue and Growth Rate (2014-2019)
Figure South Africa Rare Hematology Revenue and Growth Rate (2014-2019)
Table Global Rare Hematology Revenue (Million USD) by Type (2014-2019)
Table Global Rare Hematology Revenue Share by Type (2014-2019)
Figure Global Rare Hematology Revenue Share by Type (2014-2019)
Figure Global Rare Hematology Revenue Share by Type in 2019
Table Global Rare Hematology Revenue Forecast by Type (2019-2024)
Figure Global Rare Hematology Market Share Forecast by Type (2019-2024)
Figure Global Recombinant Factors Revenue Growth Rate (2014-2019)
Figure Global Plasma Derived Factors Revenue Growth Rate (2014-2019)
Table Global Rare Hematology Revenue by Application (2014-2019)
Table Global Rare Hematology Revenue Share by Application (2014-2019)
Figure Global Rare Hematology Revenue Share by Application (2014-2019)
Figure Global Rare Hematology Revenue Share by Application in 2019
Table Global Rare Hematology Revenue Forecast by Application (2019-2024)
Figure Global Rare Hematology Market Share Forecast by Application (2019-2024)
Figure Global Pediatric Revenue Growth Rate (2014-2019)
Figure Global Adult Revenue Growth Rate (2014-2019)
Figure Global Rare Hematology Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Rare Hematology Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Rare Hematology Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Rare Hematology Revenue Market Forecast (2019-2024)
Figure Europe Rare Hematology Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Rare Hematology Revenue Market Forecast (2019-2024)
Figure South America Rare Hematology Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Rare Hematology Revenue Market Forecast (2019-2024)
※본 조사보고서 [세계의 희귀 혈액학 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측] (코드 : GIR9075002) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 희귀 혈액학 시장 2019 : 기업별, 지역별, 종류/용도별, 시장예측] 에 대해서 E메일 문의는 여기를 클릭하세요.